US Physical Therapy (USPH) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
16 Apr, 2026Executive summary
The annual meeting is scheduled for May 19, 2026, to elect seven directors, approve executive compensation, and ratify the appointment of Grant Thornton LLP as auditor for 2026.
The board recommends voting in favor of all proposals and emphasizes the importance of shareholder participation.
Shareholders of record as of March 25, 2026, are entitled to vote, with one vote per share.
Voting matters and shareholder proposals
Proposals include election of seven directors, advisory approval of executive compensation, and ratification of Grant Thornton LLP as auditor.
The board recommends voting for all director nominees, executive compensation, and auditor ratification.
Shareholder proposals for the 2027 meeting must be submitted by February 18, 2027.
Board of directors and corporate governance
The board consists of a majority of independent directors, with Mr. Reading as Chairman/CEO and Dr. Harris as Lead Independent Director.
Four standing committees: Governance and Nominating, Compliance, Compensation, and Audit, all chaired by independent directors.
Board diversity is emphasized, with recent appointments increasing gender and ethnic diversity.
Directors are evaluated on experience, independence, and diversity; age limits apply for new and incumbent directors.
Latest events from US Physical Therapy
- Q2 2026 revenue up 8.5% year-over-year; net income fell, but margin recovery is expected.USPH
Q2 2026 - Strong organic and acquisition-driven growth, with Medicare rate tailwinds and expanding high-margin segments.USPH
The 15th Annual East Coast IDEAS Conference - Q1 2026 revenue up 7.9% to $198.3M; EBITDA guidance reaffirmed; net income declined.USPH
Q1 2026 - Record 2025 growth and new alliances position for higher 2026 EBITDA and continued expansion.USPH
Q4 2025 - Double-digit growth and high-margin expansion in injury prevention drive strong performance.USPH
16th Annual Midwest Ideas Conference - Q3 2024 delivered record patient volumes, 12% revenue growth, and major portfolio optimization.USPH
Q3 2024 - Growth continues via partnerships, acquisitions, and injury prevention despite reimbursement headwinds.USPH
15th Annual Midwest IDEAS Investor Conference - Record patient volumes and revenue growth, but net income and margins pressured by labor costs.USPH
Q2 2024 - Record Q1 patient volume, 18.1% revenue, and 23% net income growth, fueled by acquisitions.USPH
Q1 2025